In the time-stratified analysis (<8 years, 8–25 years, and >25 years), we observed suggestive but not statistically significant inverse relationships between multiple myeloma risk and TGF-α and MIP-1α marker levels in samples collected <8 years before diagnosis (Table 3). The gene discussed is CCL3; the disease is plasma cell myeloma.